ELEX Biotech LLC
About:
Elex biotech develops drugs for the treatment of cardiovascular diseases.
Website: https://www.elexbiotech.com
Top Investors: National Institutes of Health
Description:
ELEX Biotech develops small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases. These compounds modulate the function of calcium channels that control the contraction of cardiac muscle.
Total Funding Amount:
$1.4M
Headquarters Location:
Portland, Oregon, United States
Founded Date:
2009-01-01
Founders:
Doug Kawahara, Guy Salama, Jonathan Abramson, Sandra Shotwell, Xander Wehrens
Number of Employees:
1-10
Last Funding Date:
2014-11-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai